Abnormalities in apoptotic pathways lead to the development of hematological malignancies and reduce the efficacy of chemotherapy. 4 There are two interconnected pathways of apoptotic cell death; the intrinsic pathway involves the mitochondria and cytochrome C, activation of the apaf-1 complex finally culminating into caspase-9, and the extrinsic pathway, on the other hand, comprises the death receptor (DR) DR4, DR5, FAS leading to the proteolytic activation of caspase-8, 3 and 7 finally leading to cell death. Decreased susceptibility to apoptosis is an important biological feature of leukemic cells and reflects their survival potential and resistance to chemotherapeutic drugs. As a genuine hallmark of cancer, "evasion of apoptosis" has been the focus of research for many tumors in recent years. 5 Several preclinical studies have evaluated the role of extrinsic apoptotic pathway in the pathogenesis of AML. 6 However, the role of intrinsic apoptotic pathway in AML appears less clear.
Annexin-V is widely used as a marker for total apoptosis in scientific research. 7 Some preclinical studies have used caspase-9
as a marker of the intrinsic apoptotic pathway. [8] [9] [10] To date, there are no published reports correlating total apoptosis and intrinsic apoptosis with clinical outcome in pediatric AML patients. The
present study was designed to analyze total apoptosis and apoptosis induced due to intrinsic pathway, and correlate these data with clinic-pathological features and outcome in pediatric AML subjects.
| MATERIAL S AND ME THODS

| Patient's sample
This was a single-centre, prospective cohort study conducted on de novo pediatric (≤18 year) AML subjects at the tertiary cancer centre at our institute, who were registered between July 2013 and June 2016. Study was approved by the institute ethics committee.Assent form from parents was taken from subject's ≤8 years of age and informed consent was taken from rest. We excluded patients with 
| Baseline cytogenetic and molecular analysis
Pretreatment samples from all patients underwent cytogenetic analysis at NABL-accredited laboratory, and chromosomal abnor- 
| Treatment
All patients were treated on a uniform protocol. They were induced with 3 + 7 regimen (daunorubicin 60 mg/m 2 for 3 days and cytosine arabinoside 100 mg/m 2 as a 24-hour continuous infusion for 7 days). Patients, who did not achieve CR after 1st induction, were
given ADE as a 2nd induction. 15 After achieving remission, the 
| Measurement of apoptosis using Annexin-V and caspase-9
Five milliliters BM samples was collected in EDTA vials and pro- 
| Statistical analysis
Baseline characteristics for all the patients were summarized using median and range. Primary overall survival (OS) was measured as the duration from the date of enrollment to death from any cause. Eventfree survival (EFS) was measured as the duration from date of enrollment to date of relapse or death due to any cause. These data were censored at the date of last follow-up (22-December-2017) for alive patients. Annexin-V and caspase-9 expression were categorized into high or low based on their mean value. 
| RE SULTS
| Baseline parameters
A total of 200 patients were registered at the centre during the study period. Out of these, 49 were excluded from the study (five patients were acute promyelocytic leukemia, 15 patients had only one visit and 29 patients had technical failure during processing).
Therefore, 151 patients were eligible for this study. Median age was 10 years (0.7-18 years); male: female ratio was 2. had mutated FLT3-ITD while 9/122 (7.4%) had mutated NPM1.
Complete remission (CR) was achieved in 123 patients with induction chemotherapy. Median follow-up was 33.8 months. 
TA B L E 2 Association of baseline parameters and apoptosis with clinical outcomes
| Comparison of apoptosis between AML patients and controls
Annexin-V expression in blast cells ( Figure 1A -C) of AML patients was significantly higher than the lymphocytes of PB (P = 0.04) and BM (P = 0.01) controls at diagnosis ( Figure 1E ). However, intrinsic pathway of apoptosis as determined by caspase-9 expression in blast cells ( Figure 1D ) was not significantly different between AML patients, PB and BM controls ( Figure 1F ).
| Association of baseline patient's characteristics with annexin-V and caspase-9
Annexin-V was found to be significantly higher in patients with high WBC count (P = 0.02), poor-risk cytogenetics (P = 0.02), the absence of NPM1 mutation (P = 0.05), and the absence of RUNX1-RUNX1T1 translocation (P < 0.01). However, no association was observed between caspase-9 and any of the baseline patient characteristics (Table 1) .
| Association of baseline patient's characteristics, annexin-V and caspase-9 with survival outcomes
In univariate analysis, poor-risk cytogenetics adversely affected EFS and OS. Higher Annexin-V expression was significantly associated with inferior overall survival (P = 0.05) (Figure 2A ).
However, no association was found between Annexin-V and EFS (Table 2 ; Figure 2B) . No association could be demonstrated between caspase-9 with either EFS or OS (Table 2) . In multivariate analysis, karyotype was the only significant factor (P = 0.004) (Table 3 ).
| D ISCUSS I ON
Recent studies have demonstrated that the true "Achilles heel" of leukemia may be exploited by targeting both signal transduction and apoptotic programs simultaneously (synthetic lethality). 16, 17 Indeed, apoptosis has been established as a mechanism of anticancer defense and several components of the apoptotic machinery are being currently targeted in clinical trials of leukemia. 18 Although alterations in the apoptotic cascade have been revealed by studies on the genomic landscape of AML, several questions remain unanswered; which apoptotic circuitry is activated (intrinsic or extrinsic)?
Can there be some predictive biomarker for targeting apoptosis in AML? Can some reliable prognostic biomarker be identified related to these cascades?
We envisaged to explore these points and got some key find- with poor outcome, particularly in patients who do not enter CR and may serve as prognostic markers in AML. 19 Another study by our group also suggested that high BAX/BCL2 RMFI ratio was positively associated with CR rates in AML. 20 It is interesting to note that components of the intrinsic cascade upstream of the mitochondria seem to be upregulated while caspase-9 (the final components of the intrinsic cascade) is neither overexpressed nor prognostic for survival.
In a recent study by Singh et al, 21 the apoptotic index (AI) at baseline was reported to be significantly associated with poor prognostic features of pediatric ALL. We also observed a similar association of total apoptosis at baseline with features of a high-risk phenotype for pediatric AML.
Our study is unique because for the first time, we have seen the association of apoptosis at baseline directly with survival. Although apoptosis had a significant association with OS in univariate analysis TA B L E 3 Factors associated with -event-free survival and -overall survival, based on multivariate analysis it could not retain its effect in multivariate model. We hypothesized that the interaction of karyotype (a strong prognostic factor in AML)
is the reason for this effect. Larger studies would be beneficial in elucidating the exact relationship.
As more and more newer molecules targeting different components of the apoptotic circuitry are making moves into early phase clinical trials of AML, a disease which is molecularly highly heterogeneous, it becomes all the more essential to select out patients who have specific defects in the apoptotic machinery. It is also important to identify which component (intrinsic or extrinsic) is activated in a particular patient, so that we may have appropriately enriched dose expansion cohorts during these clinical trials. Markers such as
Annexin-V can thus be simple enrichments strategies.
To conclude, apoptosis as a whole was found to be activated in baseline BM samples of AML patients. High apoptosis may be associated with high-risk phenotype in this disease and the extrinsic pathway may actually be overexpressed in these clones, which is hypothesis generating.
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